Novavax Covid-19 Vaccine Adjuvanted Gets Expanded Approval In Us

Doses Of The Adjuvanted Are Available For Use In Adolescents Upon The Centers For Disease Control And Prevention'S (Cdc) Recommendation, The Company Noted. Novavax Says The Us Food And Drug Administration (Fda) Has Granted Expanded Emergency Use Authorisation For Its Covid-19 Vaccine Adjuvanted For Adolescents Aged Between 12- 17 Years. The Us Company Said The Vaccine Was The First Protein-Based Covid19 Jab Authorised In The Us, Dpa News Agency Reported. Doses Of The Adjuvanted Are Available For Use In Adolescents Upon The Centers Disease Control And Prevention'S (Cdc) Recommendation, The Company Noted. In July 2022, The Fda Had Granted Emergency Use Authorisation For A Two-Dose Primary Series In Adults Aged 18 Years And Older, Followed By A Recommendation From The Cdc Advisory Committee On Immunisation Practices, And Endorsement From The Cdc.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!